Recursion Scores $60 Million to Fund AI-Driven Drug Repurposing, Pipeline Development Post author:Sam Post published:October 3, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Amgen Faces Setback as Osteoporosis Drug is Linked to Serious Heart Side Effects May 21, 2017 Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million May 18, 2017 Wait For It! Tapped Congressman to Become the Next 'Drug Czar' April 11, 2017
Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million May 18, 2017